Negligible In Vitro Recovery of Macromolecules from Microdialysis Using 100 kDa Probes and Dextran in Perfusion Fluid

Area of Science:

• Neuroscience
• Biochemistry
• Medical Technology

Background:

• Microdialysis is crucial for monitoring cerebral glucose metabolism in neurointensive care.
• Investigating macromolecule recovery via microdialysis could identify novel biomarkers for brain diseases and their blood-brain barrier passage.

Purpose of the Study:

• To evaluate the in vitro recovery of human micro- and macromolecules using clinically approved microdialysis catheters and perfusion fluids.
• To assess the impact of different membrane cut-offs (20 kDa vs. 100 kDa) and perfusion solutions on macromolecule recovery.

Main Methods:

• In vitro microdialysis experiments were conducted using two catheter types (20 kDa and 100 kDa membrane cut-off) and varying perfusion fluids.
• Substances tested included glucose, lactate, pyruvate, human IgG, serum albumin, and hemoglobin at physiological and supraphysiological concentrations.
• Both push and push-pull microdialysis methods were employed, with sample collection every 2 hours for 6 hours.

Main Results:

• Relative recovery for glucose, pyruvate, and lactate exceeded 90% across most experiments.
• Recovery of human IgG, serum albumin, and hemoglobin was below the limit of quantification under standard conditions.
• Using a push-pull method with supraphysiological concentrations, macromolecule recovery was detectable but very low (0.9%-1.6%).

Conclusions:

• Modifying the microdialysis setup (100 kDa catheter, dextran-supplemented fluid) did not improve macromolecule recovery.
• Current microdialysis techniques are insufficient for recovering physiologically relevant macromolecules, hindering their use as biomarkers.
• Further advancements are needed to enable microdialysis detection of large molecules in brain disease research.